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The prevalence of healthcare associated
infections among adult inpatients at
nineteen large Australian acute-care public
hospitals: a point prevalence survey
Philip L. Russo1,2,3* , Andrew J. Stewardson4, Allen C. Cheng5,6, Tracey Bucknall3,5,7 and Brett G. Mitchell8,9
Abstract
Background: Australia does not have a national healthcare associated infection (HAI) surveillance program. Only
one HAI point prevalence study has been undertaken in 1984. The objective of this study was to estimate the
burden of healthcare associated infection (HAI) in acute adult inpatients in Australia.
Methods: A cross sectional point prevalence study (PPS) was conducted in a sample of large acute care hospitals.
All data were collected by two trained Research Assistants. Surveillance methodology was based on the European
Centre for Disease Prevention and Control (ECDC) PPS Protocol with variation in the sampling method in that only
acute inpatients ≥ 18 years old were included. ECDC HAI definitions were applied.
Results: Data was collected between August and November 2018. A total of 2767 patients from 19 hospitals were
included in the study. The median age of patients was 67, and 52.9% of the sample were male. Presence of a multi-
drug resistant organism was documented for 10.3% of the patients. There were 363 HAIs present in 273 patients.
The prevalence of patients with a HAI was 9.9% (95%CI: 8.8–11.0). Hospital prevalence rates ranged from 5.7%
(95%CI:2.9–11.0) to 17.0% (95%CI:10.7–26.1). The most common HAIs were surgical site infection, pneumonia and
urinary tract infection, comprising 64% of all HAIs identified.
Conclusion: This is the first HAI PPS to be conducted in Australia in 34 years. The prevalence rate is higher than the
previous Australian study and that reported by the ECDC, however differences in methodology limit comparison. Regular,
large scale HAI PPS should be undertaken to generate national HAI data to inform and drive national interventions.
Keywords: Healthcare associated infection, Infection prevention, Surveillance, Point prevalence study
Background
Healthcare associated infections (HAI) are associated
with increased morbidity and mortality, increased length
of stay, increased resistance to antimicrobials and excess
health costs [1, 2]. International studies have demon-
strated the burden of HAIs are considerable [1, 3–7].
The World Health Organisation strongly recommends
national HAI surveillance with timely data feedback and
benchmarking capacity as one of the core components
of infection prevention and control required to reduce
HAIs and antimicrobial resistance transmission [8].
Australia has some state based HAI surveillance pro-
grams primarily focused on incidence rates, and national
data is limited to S. aureus bacteraemia only [9]. There
has been only one national HAI point prevalence study
that was undertaken was in 1984 [10]. Since this time,
there have been no national studies on the burden of
HAI in Australia, one of the few developed countries
not to undertake such an exercise [11]. A recent system-
atic review, using data from peer reviewed publications
only, estimated the incidence of HAIs in Australia may
be 165,000, annually, while highlighting the scarcity of
published data [11].
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Given this absence of national data and the large re-
sources necessary for an incidence study, we performed
a national HAI point prevalence survey (PPS) in a sam-
ple of Australian acute care hospitals. The primary ob-
jectives were (1) to estimate the total prevalence of HAIs
among adult inpatients in public acute care hospitals in
Australia and (2) to describe the HAIs by site, patient
factors, medical specialty and geographical location.
Methods
Study design
We performed a rolling PPS across a sample of Austra-
lian acute care public hospitals from August 2018 to No-
vember 2018 using a modified version of the European
Centre for Disease Prevention and Control (ECDC)
methodology for PPS on HAIs [12]. Points of variation
from the ECDC method are listed in Additional file 1:
Table S1.
Hospital selection
Hospitals were recruited by seeking an expression of
interest. To maximise representation of large acute care
public facilities, we excluded specialist hospitals (e.g. ma-
ternity, cancer and paediatric hospitals) and private hos-
pitals. Jurisdictional representation was also assessed.
We included a convenience sample of hospitals cate-
gorised as either Principal Referral or Group A hospitals
according to the Australian Institute for Health and
Welfare peer groupings [13]. At the time of the study
there were 30 Principal Referral and 61 Group A hospi-
tals. The hospital recruitment process is presented in
Fig. 1.
Ward selection
All acute care inpatient wards were included with the
exception of paediatric wards, psychiatric wards (acute
and non-acute), neonatal intensive care units, rehabilita-
tion, palliative, sub-acute and long-term care wards in
acute care facilities (e.g. aged care, spinal rehabilitation
wards) and emergency departments. Wards attached to
emergency departments where patients are monitored
for more than 24 h were included.
Patient selection
Patients were systematically sampled according to a ran-
dom allocation of each ward to odd or even bed num-
bers. Randomisation was performed by the Project
Manager using a spreadsheet software randomiser. Pa-
tients in either the odd or even bed number of the allo-
cated ward were sampled, resulting in 50% of patients
on the ward being included. Patients admitted to study
wards before or at 8 am on the first survey day, and not
discharged from the ward at the time of the survey were
eligible. Patients who met the following criteria were
excluded: patients under 18 years of age (in any hospital
ward or unit), patients undergoing same day treatment
or surgery, patients seen at outpatient department, pa-
tients in the emergency room, dialysis patients
(outpatients).
Data collection and definitions
Two Research Assistants collected all data. Both Re-
search Assistants underwent 4 weeks of training in data
collection methodology and use of data collection tools.
A competency-based assessment prior to data collection
was also undertaken. Data was collected on mobile de-
vices and entered into a secure online web-based survey
tool [14]. The data collection tool designed for this study
was adapted from a previous tool developed in Research
Electronic Data Capture (REDCap) [14] that was used in
a recent Singapore study [3]. The tool included branch-
ing logics based on ECDC HAI definitions [12].
Patient level data was collected at the time of the visit
to the ward. The Research Assistants had access to hard
copy and electronic patient medical records, pathology
and microbiology databases. All these data sources were
used in determining whether a patient had a HAI,
against ECDC criteria. ECDC definitions for HAI were
used [12]. Criteria required for each HAI type were
checked against documentation recorded in the medical
records. If documentation to meet the criteria was not
identified in the medical records, then a HAI was con-
sidered not to be present. See Additional file 1: Table S2
for definitions. If after consultation with each other, the
data collectors were uncertain regarding interpretation
of documented data, one of the chief investigators (PLR,
BGM or AJS) was available to be contacted for
clarification.
Data analysis
The prevalence of HAI was estimated from the proportion
with infection in the sample. Data were analysed using
Stata V14.2 (StataCorp, College Station,Texas, USA).
Interrater reliability
Using a spreadsheet software randomiser function the
Project Manager identified one ward at each hospital for
inter-rater reliability (IRR) testing. The Research Assis-
tants separately collected data on the same patients on
that ward.
The full study protocol has previously been published
and contains further details regarding methodology [15].
Ethical considerations
The study was approved by the Alfred Health Human Re-
search Ethics Committee (HREC/17/Alfred/203) through
the Australian National Mutual Assessment process for all
states and territories except for Tasmania for which a
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separate approval was obtained from the Tasmanian
Health and Medical Human Research Committee
(H0016978) for participating Tasmanian hospitals. Site
specific authorisation was granted for each participating
hospital. The time taken to obtain all approvals was ap-
proximately 8 months.
Results
Hospital data
Nineteen hospitals participated, with representation
from each Australian state and territory except for the
Northern Territory (due to project resource limitations).
Data was collected from 6 August to 29 November 2018.
Nine hospitals were Principal Referral and ten were
Group A hospitals. Four hospitals were categorised as
Regional, all others were Major City. The total bed size
(acute and non-acute) of participating hospitals ranged
from 110 to 970 (IQR 252–589), and the median num-
ber of separations for 2017 was 46,124 (IQR 34,747-92,
309). All sites had intensive care units with bed numbers
ranging from 8 to 42 (median 18.5). Following patient
selection criteria, the number of patients sampled across
all hospitals ranged from 30 to 272.
Ward data
Data was collected from 281 wards. The most common
ward types were General Medical (49, 17.5%), General
Surgery (28, 10.0%), Cardiology (24, 8.5%), General In-
tensive Care Unit (19, 6.8%), Obstetrics/Maternity (19,
6.8%), Orthopaedics (17, 6.1%), Other Medical (12,
Fig. 1 Flow chart of hospital participation. Note: ^ Eligible hospitals were contacted using a variety of methods including email, via a professional
association network (Australasian College for Infection Prevention and Control), blogs and Twitter. Hospitals were able to register their interest by
contacting the research team. The research team maintained an expression of interest register. # The research team approached infection control
teams to consider their interest in participating. * One hospital initially agreed to participate however indicated that they could not participate
without financial support. Another site was unable to sign off on the Site Specific Assessment until the project had been reviewed by the
jurisdictional legal office which was estimated to take up to 3 months. Time restriction meant this site was omitted, and another site that had
previously shown interest was recruited
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4.3%), Respiratory (12, 4.3%), Neurology (11, 3.9%) and
Oncology (10, 3.6%).
Combined there were 6623 patient beds across all
wards. Overall, 781 (11.8%) of the beds accommodated
patients who were being managed in transmission-based
precautions.
Patient characteristics
A total of 2767 acute adult inpatients were included in
the survey (Fig. 2). The median age of patients was 67
years, ranging from 18 to 104, (IQR 49–79). Of the sam-
ple patients, 1465 (52.9%) were male, 1289 (46.6%) fe-
male and 13 (0.5%) unknown/other.
Emergency (non-elective) admissions accounted for
2330 (84.2%) of all patients. A peripheral intravascular
device was present in 1528 (55.2%) patients, a central
venous catheter was present in 410 (14.8%) patients, an
indwelling urinary catheter in 573 (20.7%) and 55 (2.0%)
were intubated.
Antimicrobial therapy (excluding surgical antimicro-
bial prophylaxis) was being administered to 1228 (44.4%)
of all patients. Overall, 285 (10.3%) patients were being
managed for the presence of at least one multi-drug re-
sistant organism (MDRO).
Table 1 summarises the overall characteristics of
patients.
HAI prevalence and distribution
A total of 363 HAIs were present in 273 patients. The
prevalence of patients with one or more HAIs was 9.9%
(95%CI: 8.8–11.0). Twelve different of HAI types were
identified; the three most common were surgical site in-
fection, (prevalence 3.6% [95%CI: 2.9–4.4], pneumonia
(prevalence 2.4% [95%CI: 1.9–3.1], and urinary tract in-
fection (prevalence 2.4% [95%CI:1.9–3.0]). These three
diagnoses accounted for 64% (233/363) of all HAIs
(Fig. 3).
Hospital prevalence rates ranged from 5.7% (95%CI:
2.9–11.0) to 17.0% (95%CI:10.7–26.1) with a median of
9.2%. Although prevalence rates varied between hospi-
tals, funnel plots suggested that this variation was within
expected statistical limits. (Additional file 1: Figure S1).
In 38 patients with a bloodstream infection, 35
(92.1%) also had a vascular device insitu. Of the 66
urinary tract infections identified, 33 (50%) of the pa-
tients had an indwelling urinary catheter, and of the
41 patients with pneumonia, 9 (22.0%) were receiving
invasive ventilation support.
Fig. 2 Process of patient selection from 281 eligible wards. *On arrival to the ward the research assistants visited every odd or even numbered
bed (according to the random allocation). If the patient in that bed had been discharged or was under 18 years of age, they were ineligible
for inclusion
Russo et al. Antimicrobial Resistance and Infection Control           (2019) 8:114 Page 4 of 8
Organism prevalence
A total of 346 organisms were identified in patients with
a HAI. The most common organisms were Staphylococ-
cus aureus (n = 50, 14.4%), Candida albicans (n = 33,
9.5%) and Escherichia coli (n = 32, 9.2%). Of the 329
MDROs identified in this cohort, the most common
were vancomycin resistant Enterococcus (n = 113, 4.1%),
methicillin resistant S. aureus 101 (3.7%), and extended
spectrum beta-lactamase-producing Enterobacteriaceae
67 (2.4%).
Organisms by infection type are listed in Table 2.
Reliability
Interrater reliability assessment was measured from a
sample of 146 patients from 14 facilities and suggested
high agreement (Kappa 0.92).
Table 1 Characteristics of patients with and without healthcare associated infection
Factor All patients
(n = 2767)
Patients without HAI
(n = 2494)
Patients with HAI
(n = 273)
Patient Characteristics
Male 1465 (52.9%) 1297 (52.0%) 168 (61.5%)
Age group
≤ 29 179 (6.5%) 169 (6.8%) 10 (3.7%)
30–39 243 (8.8%) 226 (9.1%) 17 (6.2%)
40–49 276 (10.0%) 244 (9.8%) 32 (11.7%)
50–59 352 (12.7%) 301 (12.1%) 51 (18.7%)
60–69 498 (18.0%) 442 (17.7%) 56 (20.5%)
70–79 585 (21.1%) 529 (21.2%) 56 (20.5%)
≥ 80 634 (22.9%) 583 (23.4%) 51 (18.7%)
Emergency admission 2330 (84.2%) 2100 (84.2%) 230 (84.2%)
Receiving antimicrobial therapya 1228 (44.4%) 961 (38.6%) 267 (97.8%)
Documented fever > 38 °C in last 24 h 161 (5.8%) 124 (5.0%) 37 (13.6%)
Current colonisation or infection with multi-resistant organism 285 (10.3%) 219 (8.8%) 66 (24.2%)
Exposures
Peripheral vascular access device present 1528 (55.2%) 1383 (55.6%) 145 (53.1%)
Central vascular access device present 410 (14.8%) 303 (12.2%) 107 (39.2%)
Indwelling urinary catheter present 573 (20.7%) 483 (19.4%) 90 (33.0%)
Ventilated 55 (2.0%) 40 (1.6%) 15 (5.5%)
Length of stay – median days (IQR) 5 (2–10) 4 (2–8) 14 (7–28)
Medical Specialty
Intensive Care Unit 170 (6.1%) 128 (5.1%) 42 (15.4%)
General Medicine 557 (20.1%) 513 (20.6%) 44 (16.1)
General Surgery 307 (11.1%) 261 (10.5%) 46 (16.5%)
Orthopaedics 205 (7.4%) 174 (7.0%) 31 (11.4%)
Cardiology 201 (7.3%) 191 (7.7%) 10 (3.7%)
Other 1327 (48.0%) 1267 (50.8%) 173 (63.4%)
Hospital Peer Group
Principal Referral 1937 (70.0%) 1739 (69.7%) 198 (72.5%)
Group A hospital 830 (30.0%) 755 (30.3%) 75 (27.5%)
Location
Major city hospital 2371 (85.7%) 2146 (86.0%) 225 (82.4%)
Regional 396 (14.3%) 348 (14.0%) 48 (17.6%)
Data are n (%) unless otherwise stated
HAI healthcare associated infection, IQR interquartile range
aExcluding surgical antimicrobial prophylaxis
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Discussion
This is the first Australian multicentred national HAI
point prevalence study for 34 years. Importantly this
study reveals that on any given day, one in every ten
acute adult inpatients has at least one HAI. Further-
more, one in every ten acute adult patients is colo-
nised or infected with a multi-resistant organism.
Similar to the results from ECDC prevalence surveys,
the three most common HAIs identified were surgical
site infection, healthcare associated pneumonia and
urinary tract infection [5]. These data also clearly
demonstrate that patients with vascular, urinary and
respiratory devices have a higher prevalence of HAI,
and the prevalence of infection in the acute care set-
ting increases with age.
The HAI prevalence rate of 9.9% is higher than that
reported by the ECDC (6.0%) [5] and in recent studies
conducted in Switzerland and Scotland (5.6 and 4.6% re-
spectively) [4, 6], yet slightly lower than that reported re-
cently in Singapore (11.9%) [3] and Japan (10.1%) [16]
where the same ECDC HAI definitions were used. It is
more than twice the rate reported in a USA multistate
study (4.0%) [1], though lower than a Canadian study
(10.5%) [17], however these studies used slightly differ-
ent and previous versions of Centers for Disease Control
(CDC) HAI definitions [18]. The variation in inter-
national rates may reflect a real difference in the risk of
HAIs across countries or differences in healthcare
systems (e.g. casemix, length-of-stay, use of Hospital-in-
the-Home) and study design (e.g. hospital type).
Fig. 3 Distribution of healthcare associated infection type (rate with 95% confidence intervals)
Table 2 Organism frequency by common healthcare associated infection
Surgical site infection Pneumonia Urinary tract infection Bloodstream infection
Patients with HAI (n) 100 67 66 38
Number of organisms
identified (n)
97 38 61 37
Organism (frequency) S. aureus (21.6%) S. aureus (13.2%) E. coli (31.1%) S. aureus (18.9%)
Gram positive bacilli (11.3%) Candida spp. (10.5%) Candida spp. (21.3%) E. coli (16.2%)
C. albicans (7.2%) Gram negative bacilli (7.9%) E. faecium (16.4%) Enterococcus spp. (13.5%)
Enterococcus spp. (7.2%) Gram negative cocci (7.9%) Klebsiella spp. (13.1%) Candida spp. (10.8%)
P. aeruginosa (7.2%) H. influenzae (7.9%) Gram positive bacilli (6.6%) Klebsiella spp. (8.1%)
Klebsiella spp. (7.9%) Streptococcus spp. (8.1%)
P. aeruginosa (7.9%)
HAI healthcare associated infection
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However, differences in the patient populations (most
include all acute patients), slight variation in data collec-
tion methods and use of either ECDC or CDC HAI defi-
nitions across these studies means data cannot be
directly compared.
Over the past 20 years there has been significant invest-
ment at both national and jurisdictional level in HAI pre-
vention in Australia. The National Hand Hygiene
Initiative was introduced in 2008 [19]. The Australian
Guidelines for the Prevention and Control of Infection in
Healthcare were first released in 2010 [20]. The National
Safety and Quality Health Service Standards were released
in 2011 [21]. Furthermore, in some jurisdictions, central
support of infection prevention and surveillance is now
well established [22–24]. Despite these investments, this
study identified a prevalence rate higher than the 1984
Australian study of 6.3%. This difference could be ex-
plained by true differences in the prevalence of infection,
changes in health care (e.g. use of invasive devices or sur-
gery), the susceptibility of the patient group, or differences
in methods and definitions [10]. Nonetheless, our findings
demonstrate that despite investment in infection preven-
tion and control activities, HAIs remain a significant bur-
den for health services and patients. Continued investment
in infection prevention and control strategies at the health
service/district, jurisdictional and national level is war-
ranted, in addition to support for research that provides
evidence for prevention strategies. Data from point preva-
lence studies and a future national surveillance program
should be used to inform priorities for future investment.
This study has several strengths. First is it based on
established and validated methodology from the ECDC.
Second, the use of the same trained data collectors
across all sites, ensured consistency, and also negated
any subjective influences if it were data from hospital
based collectors. This is a critical difference to other
international PPS and adds reliability to our study. While
using a small number of trained staff limits scalability of
future work, we feel that training and evaluation of those
collecting data is important in considering future work.
We encountered no significant issues in obtaining or
accessing relevant patient data to determine whether a
patient had a HAI.
Limitations of this work include the potential for se-
lection bias, as hospitals were not randomly selected to
participate. Second, as only large public adult hospitals
were included, these results cannot necessarily be ex-
trapolated to smaller public hospitals, the private sector,
or paediatric centres or patients. We elected to focus on
large public hospitals to generate a precise estimate in
this cohort which is likely to have the highest burden of
HAIs (given patient casemix). Third, we did not collect
patient-level factors (such as comorbidities or severity of
illness) to permit patient-level risk adjustment.
Conclusion
National HAI prevention initiatives must be guided by
national data. That Australia does not have national sur-
veillance of HAIs means the effect of national initiatives
to prevent HAIs cannot be measured. This study has
provided the first estimate of the prevalence of HAI in
34 years, however to gain a deeper understanding of the
true burden HAIs in Australia, larger HAI PPS studies
across broader patient populations are required.
If Australia is to succeed in addressing HAIs and the
emerging threat of MDROs, national leadership and coord-
ination is required to implement a national protocol for
regular point prevalent surveillance to inform and drive
Australian healthcare infection prevention initiatives.
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